首页> 美国卫生研究院文献>The Canadian Veterinary Journal >Anesthesia of wood bison with medetomidine-zolazepam/tiletamine and xylazine-zolazepam/tiletamine combinations.
【2h】

Anesthesia of wood bison with medetomidine-zolazepam/tiletamine and xylazine-zolazepam/tiletamine combinations.

机译:美托咪定-左拉西坦/左旋多巴胺和甲苯噻嗪-左拉西坦/左旋多巴胺组合麻醉木材野牛。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study was designed to evaluate 2 combinations for immobilization of bison. Seven wood bison received 1.5 mg/kg body weight (BW) of xylazine HCl + 1.5 mg/kg BW of zolazepam HCl and 1.5 mg/kg BW of tiletamine HCl on one occasion. The bison received 60 micrograms/kg BW of medetomidine HCl + 0.6 mg/kg BW of zolazepam HCl and 0.6 mg/kg BW of tiletamine HCL on another occasion. Xylazine was antagonized with 3 mg/kg BW of tolazoline HCl and medetomidine HCl was antagonized with 180 micrograms/kg (BW) of atipamezole HCl. Temporal characteristics of immobilization and physiological effects (acid-base status, thermoregulatory, cardiovascular, and respiratory effects) of the drug combinations were compared. Induction was significantly faster with xylazine HCl-zolazepam HCl/tiletamine HCl. Recovery following antagonist administration was significantly faster with medetomidine HCl-zolazepam HCl/tiletamine HCl. The average drug volumes required were 7.00 mL of xylazine HCl-zolazepam HCl/tiletamine HCL and 2.78 mL of medetomidine HCl-zolazepam HCl/tiletamine HCl. Hypoxemia, hypercarbia, and rumenal tympany were the major adverse effects with both drug combinations.
机译:这项研究旨在评估固定野牛的2种组合。七只野牛一次接受1.5 mg / kg体重(BW)的盐酸赛拉嗪+ 1.5 mg / kg体重的唑拉西坦HCl和1.5 mg / kg体重的瓦他敏HCl。在另一情况下,野牛接受60毫克/千克体重的美托咪定HCl + 0.6毫克/千克体重的唑拉西坦HCl和0.6毫克/千克体重的瓦他敏盐酸盐。甲苯噻唑与3 mg / kg体重的甲苯磺酸托拉唑啉拮抗,而美托咪定HCl与180毫克/ kg(BW)的盐酸阿替哌唑拮抗。比较了固定的时间特性和药物组合的生理效应(酸碱状态,温度调节,心血管和呼吸效应)。用盐酸赛拉嗪-盐酸唑拉西坦/盐酸替他敏的诱导明显更快。使用美托咪定HCl-左唑西am HCl /盐酸替他敏HCl后,拮抗剂给药后的恢复明显更快。所需的平均药物量为7.00 mL盐酸甲苯噻嗪-盐酸左拉西帕姆/盐酸替他敏和2.78 mL盐酸美托咪定盐酸-左唑西坦/盐酸维他命胺。低氧血症,高碳酸血症和瘤胃气喘是两种药物联合使用的主要不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号